Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Androgens affect many aspects of female health, and more research is needed to understand their roles and treatment potential.

Young men with mild hair loss who experience significant social and emotional distress are more likely to have sexual problems.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

Testosterone is important for men's sexual function, may help some women's sexual desire, while other hormones and neurotransmitters also play complex roles in sexual behavior.

Flibanserin shows promise for treating male sexual dysfunction but has side effects like insomnia and fatigue.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone in older women can increase bone density, muscle mass, fat mass, improve memory, and boost libido, but may cause nipple color changes.

Breast cancer survivors often face body image and sexual health issues, needing ongoing support and open communication with healthcare providers.

Gendered social factors, not just biology, contribute to sex differences in adverse drug events.

Polycystic ovary syndrome (PCOS) significantly impacts women's emotional well-being and social lives, requiring treatments that include psychological support.

Gender identity can be more diverse than just male or female.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Women with PCOS often experience depression and anxiety, affecting their quality of life.

The document concludes that transsexual individuals often experience improved quality of life after transitioning, despite higher risks of psychiatric issues and mortality.

A 31-year-old woman was diagnosed with Complete Androgen Insensitivity Syndrome much later than usual, leading to a call for earlier detection and treatment guidelines.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Finasteride helps female-pattern hair loss.

Finasteride for female hair loss has low side effects, more research needed.

Technology can improve sexual dysfunction in chronic disease patients but faces challenges like cost and accessibility.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Many young women in Pakistan are unaware of their PCOS symptoms.